DJ Insulet Corp. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. $(PODD)$ slipped 1.22% to $263.33 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.73% to 5,974.07 and the Dow Jones Industrial Average rising 0.16% to 42,906.95.
The stock's fall snapped a two-day winning streak.
Insulet Corp. closed $16.44 short of its 52-week high ($279.77), which the company reached on December 12th.
The stock underperformed when compared to some of its competitors Monday, as Eli Lilly & Co. $(LLY)$ rose 3.71% to $796.28, DexCom Inc. $(DXCM)$ fell 0.62% to $79.54, and Johnson & Johnson $(JNJ)$ rose 0.55% to $145.27.
Trading volume (493,746) remained 92,488 below its 50-day average volume of 586,234.
Data source: Dow Jones Market Data, FactSet. Data compiled December 23, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 23, 2024 17:15 ET (22:15 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。